[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-what-is-william-blairs-estimat3301959474-6c7d-7d5c-b384-af2f3c6b8317":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":21},"what-is-william-blairs-estimat3301959474-6c7d-7d5c-b384-af2f3c6b8317","1741951716000","What is William Blair's Estimate for MaxCyte Q1 Earnings?","MaxCyte, Inc. (NASDAQ:MXCT - Free Report) - Equities research analysts at  William Blair issued their Q1 2026 earnings estimates for MaxCyte  in a report released on  Wednesday, March 12th. William Blair analyst M. Larew expects that the company will post earnings per share of ($0.09) for the quarte","https://www.marketbeat.com/instant-alerts/what-is-william-blairs-estimate-for-maxcyte-q1-earnings-2025-03-13/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"\",\"-\"]","[{\"name\":\"\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/blockchains/.png\"},{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN"]